Search
Garden snail mucin
go.drugbank.com/drugs/DB14244InvestigationalGarden snail mucin is an animal extract used in some OTC (over-the-counter) products. It is not an approved drug.
Marine collagen, soluble
go.drugbank.com/drugs/DB14246InvestigationalMarine collagen, soluble is an animal extract used in some OTC (over-the-counter) products. It is not an approved drug.
Argan oil
go.drugbank.com/drugs/DB14310InvestigationalArgan oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Macadamia oil
go.drugbank.com/drugs/DB14330InvestigationalMacadamia oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Tribulus terrestris
go.drugbank.com/drugs/DB14358InvestigationalTribulus terrestris is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
KD3010
go.drugbank.com/drugs/DB05188ExperimentalKD3010 is a small molecule peroxisome proliferator-activator receptor delta (PPAR Delta) agonist for the treatment of metabolic disorders, including obesity.
Febuxostat
go.drugbank.com/drugs/DB04854ApprovedInvestigationalFebuxostat is a non-purine xanthine oxidase (XO) inhibitor. In early 2008, febuxostat was granted marketing authorization by the European Commission for the treatment of chronic hyperuricemia and gout. In the following year, the FDA for ...
Dextromethorphan
go.drugbank.com/drugs/DB00514ApprovedInvestigationalDextromethorphan is a levorphanol derivative and codeine analog commonly used as a cough suppressant and also a drug of abuse. Although similar in structure to other opioids, it has minimal interaction with opioid receptors. Dextromethor...
Cupric oxide
go.drugbank.com/drugs/DB11134ApprovedCupric oxide may be found in over-the-counter vitamin-mineral supplements as a source of [DB09130]. The mean daily dietary intake of copper in adults ranges between 0.9 and 2.2 mg [L2422].
Mixtures: Multi-Nate 30, Vol-NateSipuleucel-T
go.drugbank.com/drugs/DB06688ApprovedInvestigationalThe treatment initially cost $93,000 at the time of FDA approval, but rose to over $100,000 in 2014.